Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-Q
Source: 0001640334-25-001302
Chunk: 2

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-Q
Item: Item 1
Chunk 2
---
  $-   60,042,000  $60,042  $32,298,442  $(32,615,498) $(257,014)                             Imputed interest on related party loans  -   -   -   -   954   -   954 Net loss  -   -   -   -   -   (11,252)  (11,252)                             Balance, March 31, 2024  -  $-   60,042,000  $60,042  $32,299,396  $(32,626,750) $(267,312)

The accompanying notes are an integral part of these unaudited financial statements.

 6Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Cash Flows

(Unaudited)

   Three months ended     March 31,    2025  2024        CASH FLOWS FROM OPERATING ACTIVITIES      Net loss $(10,301) $(11,252)Adjustments to reconcile net loss to net cash used in operating activities:        Imputed interest - related parties  1,367   954 Changes in operating assets and liabilities:        Prepaid expenses  -   1,250 Operating lease liability  (2,315)  (2,315)Accounts payable and accrued expenses  (11,282)  (2,150)Net cash used in operating activities  (22,531)  (13,513)         CASH FLOWS FROM FINANCING ACTIVITIES        Advances from related parties  22,306   13,288 Net cash provided by financing activities  22,306   13,288          Net change in cash  (225)  (225)Cash at beginning of period  476   376 Cash at end of period $251  $151          SUPPLEMENTAL CASH FLOW INFORMATION:        Cash paid for income taxes $-  $- Cash paid for interest $-  $- 

The accompanying notes are an integral part of these unaudited financial statements.

 7Table of Contents